Qiagen NV (QGEN) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

QGEN Qiagen NV

Watchlist

45.265
+0.325+0.72%

Trading Jan 8 13:36 ET

10.06BMarket Cap113.16P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Morgan Stanley Downgrades Qiagen NV(QGEN.US) to Hold Rating, Cuts Target Price to $48
Moomoo NewsJan 6 03:31 ET · Ratings
Express News | Qiagen NV : Morgan Stanley Cuts to Equal-Weight From Overweight; Cuts Target Price to $48 From $50
ReutersJan 6 01:47 ET
Why Is Qiagen N.V. (QGEN) Among the Top CRISPR Stocks to Invest In?
Yahoo FinanceDec 30, 2024 15:45 ET
Qiagen N.V.'s (NYSE:QGEN) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Simply Wall StDec 25, 2024 07:53 ET
BofA Securities Maintains Qiagen NV(QGEN.US) With Buy Rating
Moomoo NewsDec 16, 2024 09:31 ET · Ratings
QIAGEN Stock Gains Following the Latest Launch of IPA Interpret
Zacks Dec 13, 2024 07:30 ET

Comments

Lnova

Nov 17, 2024 15:34

QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database
Article from late September…
forensic genealogy
$Qiagen NV (QGEN.US)$

Moomoo AI

Jan 8, 2024 08:29

Qiagen's high P/E ratio is worrisome due to its poor earnings forecast. Despite the high P/E, investors retain their shares, but this earnings growth rate may eventually impact the share price. The high P/E and future earnings predictions pose a substantial risk to shareholders and potential investors.

There's Reason For Concern Over Qiagen N.V.'s (NYSE:QGEN) Price

Moomoo AI

Dec 24, 2023 06:27

Qiagen's performance is strong due to strategic profit reinvestment, leading to significant earnings growth. Its respectable ROE contributes to a net income increase. Yet, forecasts anticipate a slowdown in future earnings growth.